Rv2043c - p.Val21Gly
Drug resistance types
0 Sensitive
0 RR-TB
0 HR-TB
27 MDR-TB
4 Pre-XDR-TB
0 XDR-TB
0 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.1.1 | 14 |
| lineage4.1.1;lineage4.1.2.1;lineage4.3.4.2 | 1 |
| lineage2.2.1 | 10 |
| lineage3.1.1 | 1 |
| lineage4.1.1.3 | 1 |
| lineage3 | 1 |
| lineage1.2.2.2 | 2 |
| lineage1.1.1.1 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 31 |
Geographic prevalence
Country level data for this variant is available for 7 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR28394050 | MDR-TB | lineage4.1.1 | None | SRR28393580 | MDR-TB | lineage4.1.1 | None | SRR28394204 | MDR-TB | lineage4.1.1 | None | SRR28394179 | MDR-TB | lineage4.1.1 | None | SRR28393663 | MDR-TB | lineage4.1.1;lineage4.1.2.1;lineage4.3.4.2 | None | SRR26936962 | MDR-TB | lineage2.2.1 | None | SRR24256100 | MDR-TB | lineage2.2.1 | None | ERR550764 | MDR-TB | lineage3.1.1 | None | ERR3287814 | MDR-TB | lineage4.1.1.3 | pe | ERR552008 | MDR-TB | lineage2.2.1 | None | SRR15014672 | MDR-TB | lineage3 | None | ERR11081278 | MDR-TB | lineage2.2.1 | None | ERR4830996 | Pre-XDR-TB | lineage2.2.1 | np | ERR114452 | MDR-TB | lineage1.2.2.2 | None | SRR28393357 | MDR-TB | lineage4.1.1 | None | SRR28394069 | MDR-TB | lineage4.1.1 | None | SRR28393310 | MDR-TB | lineage4.1.1 | None | SRR28394261 | MDR-TB | lineage4.1.1 | None | ERR12790851 | MDR-TB | lineage1.1.1.1 | None | SRR28394138 | MDR-TB | lineage4.1.1 | None | SRR28394037 | Pre-XDR-TB | lineage4.1.1 | None | ERR2516724 | MDR-TB | lineage4.1.1 | pe | SAMEA2534347 | MDR-TB | lineage2.2.1 | uz | ERR552007 | MDR-TB | lineage2.2.1 | None | SRR24256179 | MDR-TB | lineage2.2.1 | None | ERR2677426 | MDR-TB | lineage2.2.1 | de | ERR2516713 | MDR-TB | lineage4.1.1 | pe | ERR2516499 | Pre-XDR-TB | lineage4.1.1 | pe | ERR4813123 | Pre-XDR-TB | lineage4.1.1 | None | ERR552008_ERR552007 | MDR-TB | lineage2.2.1 | None | SRR2100301 | MDR-TB | lineage1.2.2.2 | None |
|---|
